Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06199154 · ClinicalTrials.gov registry record · Early Phase 1

Induction of Labor in Morbidly Obese Patients

A Early Phase 1 study of Pregnancy and Morbid Obesity, sponsored by University of Maryland, Baltimore.

Recruiting
Registry status
Early Phase 1
Development phase
162
Enrollment target
1
Study location

NCT06199154 is a Early Phase 1 study of Pregnancy and Morbid Obesity that is actively recruiting participants, run by University of Maryland, Baltimore. The registered enrollment target is 162 participants, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06199154, a Early Phase 1 study of Pregnancy and Morbid Obesity, is actively recruiting participants, sponsored by University of Maryland, Baltimore.

RECRUITING
Registry status
Early Phase 1
Development phase
162 participants
Enrollment target
1
Study location

Study Summary

The goal of this randomized control trial is to compare different doses of Misoprostol (25 mcg vs 50 mcg) in induction of labor (IOL) in morbidly obese patients with BMI \>40. It is known that morbid obesity is a risk factor for failed IOL and ultimately cesarean delivery (CD.) If the rates of vaginal delivery in this population can improve, then surgical morbidity can be reduced in these patients.

Conditions Studied

Interventions

  • DRUG Misoprostol

Study Locations (1)

Maryland

  • University of Maryland Medical Center - Baltimore

Trial Details

FieldValue
Enrollment Target 162 participants
Start Date 2024-07-15
Est. Completion 2026-10
Phase Early Phase 1

Sponsor

University of Maryland, Baltimore

560 total trials

What the Registry Record Tells You About NCT06199154

The ClinicalTrials.gov registry entry for NCT06199154 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 162 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (81% lower). The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which Misoprostol is the first listed.

NCT06199154 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT06199154 about?

NCT06199154 is a clinical study titled "Induction of Labor in Morbidly Obese Patients". The goal of this randomized control trial is to compare different doses of Misoprostol (25 mcg vs 50 mcg) in induction of labor (IOL) in morbidly obese patients with BMI \>40. It is known that morbid obesity is a risk factor for failed IOL and ultimately cesarean delivery (CD.) If the rates of vagin...

What is the current status of trial NCT06199154?

This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 162 participants. The study started on 2024-07-15. Estimated completion is 2026-10.

What conditions does trial NCT06199154 study?

This clinical trial studies the following conditions: Pregnancy, Morbid Obesity.

What interventions are being tested in trial NCT06199154?

The interventions under investigation include: Misoprostol (DRUG).

Who is sponsoring clinical trial NCT06199154?

This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06199154 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pregnancy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.